Huakang Biomedical Holdings Company Limited (8622.HK)
HKD 0.18
(1.67%)
HKD 0.18
(1.67%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 24.62 Million | 25.33 Million | 26.12 Million | 21.96 Million | 25.47 Million | 28.67 Million |
| Cost of Revenue | 8.53 Million | 8.41 Million | 9.67 Million | 7.24 Million | 7.58 Million | 7.09 Million |
| Gross Profit | 16.09 Million | 16.91 Million | 16.45 Million | 14.71 Million | 17.89 Million | 21.58 Million |
| Operating Expenses | 16.09 Million | 21.27 Million | 20.23 Million | 22.56 Million | 18.12 Million | 18.97 Million |
| Selling, General and Administrative Expenses | 18.49 Million | 18.75 Million | 17.69 Million | 17.31 Million | 16.45 Million | 17.64 Million |
| Research and Development Expenses | 3.23 Million | 2.48 Million | 2.43 Million | 2.25 Million | 1.76 Million | 1.47 Million |
| Other Expenses | - | 37 Thousand | 100 Thousand | 2.99 Million | -94 Thousand | -150 Thousand |
| Cost and Expenses | 32.02 Million | 29.69 Million | 29.9 Million | 29.81 Million | 25.7 Million | 26.06 Million |
| Operating Income | -7.39 Million | -2.95 Million | -3.8 Million | -8.74 Million | 470 Thousand | 2.6 Million |
| Interest Expense | 53 Thousand | 55 Thousand | 102 Thousand | 74 Thousand | 72 Thousand | 1.36 Million |
| Income Tax Expense | - | 68 Thousand | 317 Thousand | 255 Thousand | 942 Thousand | 1.7 Million |
| Earnings before Tax | -5.78 Million | -3 Million | -3.9 Million | -11.37 Million | 658 Thousand | 1.24 Million |
| Net Income | -5.78 Million | -3.07 Million | -4.22 Million | -11.62 Million | -284 Thousand | -459 Thousand |
| Earnings Per Share Basic | -0.01 | -0.01 | -0.01 | -0.03 | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.01 | -0.01 | -0.01 | -0.03 | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 415.96 Million | 404.63 Million | 400 Million | 400 Million | 400 Million | 305.2 Million |
| Weighted Average Shares Outstanding (Diluted) | 415.96 Million | 404.63 Million | 400 Million | 400 Million | 400 Million | 305.2 Million |
| Gross Margin | 0.65 | 0.67 | 0.63 | 0.67 | 0.70 | 0.75 |
| EBIT Margin | -0.10 | 0.01 | -0.03 | -0.25 | 0.13 | 0.15 |
| Profit Margin | -0.23 | -0.12 | -0.16 | -0.53 | -0.01 | -0.02 |
| EBITDA | -2.55 Million | 188 Thousand | -852 Thousand | -8.1 Million | 3.49 Million | 4.29 Million |
| Earnings Before Tax Margin | -0.30 | -0.12 | -0.15 | -0.40 | 0.02 | 0.09 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 5.95 Million | 5.95 Million | 6.85 Million | 24.62 Million | 6.3 Million | 5.7 Million |
| Cost of Revenue | 1.96 Million | 1.96 Million | 2.43 Million | 8.53 Million | 2.18 Million | 2.03 Million |
| Gross Profit | 3.99 Million | 3.99 Million | 4.42 Million | 16.09 Million | 4.12 Million | 3.66 Million |
| Operating Expenses | 5.27 Million | 5.27 Million | 8.2 Million | 22.57 Million | 4.98 Million | 5.25 Million |
| Selling, General and Administrative Expenses | 4.1 Million | 4.1 Million | 6.35 Million | - | 4.16 Million | 4.28 Million |
| Research and Development Expenses | 1.16 Million | 1.16 Million | 128 Thousand | - | 826 Thousand | 856 Thousand |
| Other Expenses | - | - | -111 Thousand | 99 Thousand | 72 Thousand | 125 Thousand |
| Cost and Expenses | 7.24 Million | 7.24 Million | 10.63 Million | 31.11 Million | 7.16 Million | 7.28 Million |
| Operating Income | -1.28 Million | -1.28 Million | -3.3 Million | -6.71 Million | -811 Thousand | -933 Thousand |
| Interest Expense | - | - | 27 Thousand | 53 Thousand | 11 Thousand | 8000.00 |
| Income Tax Expense | 169.49 Thousand | 169.49 Thousand | -3000.00 | 985 Thousand | -53 Thousand | -488.5 Thousand |
| Earnings before Tax | -889.5 Thousand | -889.5 Thousand | -3.28 Million | -5.78 Million | -1.09 Million | -941 Thousand |
| Net Income | -889.5 Thousand | -889.5 Thousand | -3.28 Million | -5.78 Million | -1.04 Million | -941 Thousand |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.01 | - | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.01 | - | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 464.49 Million | 464.49 Million | 418.52 Million | 415.96 Million | 416.38 Million | 414.47 Million |
| Weighted Average Shares Outstanding (Diluted) | 464.3 Million | 464.3 Million | 418.49 Million | 415.96 Million | 416.38 Million | 414.47 Million |
| Gross Margin | 0.67 | 0.67 | 0.65 | 0.65 | 0.65 | 0.64 |
| EBIT Margin | -0.12 | -0.12 | -0.48 | - | -0.13 | -0.16 |
| Profit Margin | -0.15 | -0.15 | -0.48 | -0.23 | -0.17 | -0.16 |
| EBITDA | -699 Thousand | -699 Thousand | -3.26 Million | - | -811 Thousand | -933 Thousand |
| Earnings Before Tax Margin | -0.22 | -0.22 | -0.48 | -0.27 | -0.13 | -0.16 |
MGRB
4559
206A
MBX
NWL
SQM-B